BioMarin prices hemophilia gene therapy at nearly 29,000 euros per vial in Germany

[ad_1] Nov 28 (Reuters) – BioMarin Pharmaceutical (BMRN.O) said on Tuesday it will price its therapy for severe hemophilia A at 28,933.53 euros ($31,725.62) per vial for insurers covering a…

Exclusive: Cigna explores shedding Medicare Advantage business -sources

[ad_1] Signage for Cigna is pictured at a health facility in Queens, New York City, U.S., November 30, 2021. REUTERS/Andrew Kelly/File Photo Acquire Licensing Rights NEW YORK, Nov 6 (Reuters)…

Boehringer launches 81% discounted biosimilar of AbbVie’s Humira

[ad_1] The logo of German pharmaceutical company Boehringer Ingelheim is seen at its building in Shanghai, China February 1, 2019. REUTERS/Stringer/File Photo Acquire Licensing Rights Oct 2 (Reuters) – Germany’s…

Centene to cut about 2,000 jobs

[ad_1] Sept 26 (Reuters) – Health insurer Centene (CNC.N) will lay off 3% of its workforce, or about 2,000 employees, a company spokesperson said on Tuesday as the company tries…

Australia regulator tells Medibank to set aside $167 mln after data breach

[ad_1] Shares down as much as 4.6%, worst day since Oct. 26 Medibank says has sufficient capital Capital returns apart from dividend unlikely in near-term-analyst SYDNEY, June 27 (Reuters) –…

Insurer AIG exceeds profit estimates on strong underwriting gains

[ad_1] May 4 (Reuters) – American International Group Inc (AIG.N) beat market estimates for first-quarter profit on Thursday, as record underwriting gains cushioned the blow from lower alternative investment returns.…

Prudential Financial profit misses on lower assets under management

[ad_1] May 2 (Reuters) – Prudential Financial Inc (PRU.N) reported a lower-than-expected quarterly profit on Tuesday, as the life insurer saw a decline in assets under management. The respite in…